 | • レポートコード：QFJ1-5592 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、抗ウイルス漢方薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗HIV、抗CVB、抗HBV、抗インフルエンザウイルス、抗ヘルペスウイルス、その他）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・抗ウイルス漢方薬の市場動向 ・企業の競争状況、市場シェア ・抗ウイルス漢方薬の種類別市場規模と予測2016-2027（抗HIV、抗CVB、抗HBV、抗インフルエンザウイルス、抗ヘルペスウイルス、その他） ・抗ウイルス漢方薬の用途別市場規模と予測2016-2027（大人用、子供用） ・抗ウイルス漢方薬の北米市場規模2016-2027（アメリカ、カナダ） ・抗ウイルス漢方薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗ウイルス漢方薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗ウイルス漢方薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗ウイルス漢方薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Guangzhou Pharmaceutical、CR SANJIU、TASLY、China TCM、Yunnan Baiyao、Tongrentang、Jumpcan、Zhejiang Conba Pharmaceutical、Green Valley Pharma、Changbaishan Pharmaceutical、Zhejiang Kanglaite Pharmaceutical、Qingfeng Pharmaceutical Group、Buchang Pharmaceutical、Livzon、ZBD Pharmaceutical、Chase Sun Pharmaceutical、Wuzhou Pharmaceutical、Yusheng Pharmaceutical、Harbin Pharmaceutical Group、Fusen Pharmaceutical、Gerun Pharmaceutical、Shineway Pharmaceutical、Yiling Pharmaceutical、Harbin Pharmaceutical Group） ・結論 |
Anti-viral traditional Chinese medicine mainly includes anti-HIV, anti-CVB, anti-HBV, anti-influenza virus, anti-herpes virus traditional Chinese medicine. At present, the COVID-19c epidemic is progressing rapidly, and Chinese medicine has a long history. It plays an indispensable role in the prevention and treatment of various epidemics. During the treatment of COVID-19, the intervention of Chinese medicine has also achieved remarkable results.
Market Analysis and Insights: Global Antiviral Traditional Chinese Medicine Market
The global Antiviral Traditional Chinese Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antiviral Traditional Chinese Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antiviral Traditional Chinese Medicine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antiviral Traditional Chinese Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antiviral Traditional Chinese Medicine market.
Global Antiviral Traditional Chinese Medicine Scope and Market Size
Antiviral Traditional Chinese Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antiviral Traditional Chinese Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Anti-HIV
Anti-CVB
Anti-HBV
Anti-influenza Virus
Anti-herpes Virus
Other
Segment by Application
Adult
Children
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Guangzhou Pharmaceutical
CR SANJIU
TASLY
China TCM
Yunnan Baiyao
Tongrentang
Jumpcan
Zhejiang Conba Pharmaceutical
Green Valley Pharma
Changbaishan Pharmaceutical
Zhejiang Kanglaite Pharmaceutical
Qingfeng Pharmaceutical Group
Buchang Pharmaceutical
Livzon
ZBD Pharmaceutical
Chase Sun Pharmaceutical
Wuzhou Pharmaceutical
Yusheng Pharmaceutical
Harbin Pharmaceutical Group
Fusen Pharmaceutical
Gerun Pharmaceutical
Shineway Pharmaceutical
Yiling Pharmaceutical
Harbin Pharmaceutical Group
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiviral Traditional Chinese Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-HIV
1.2.3 Anti-CVB
1.2.4 Anti-HBV
1.2.5 Anti-influenza Virus
1.2.6 Anti-herpes Virus
1.2.7 Other
1.3 Market by Application
1.3.1 Global Antiviral Traditional Chinese Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Adult
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antiviral Traditional Chinese Medicine Market Perspective (2016-2027)
2.2 Antiviral Traditional Chinese Medicine Growth Trends by Regions
2.2.1 Antiviral Traditional Chinese Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antiviral Traditional Chinese Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Antiviral Traditional Chinese Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Antiviral Traditional Chinese Medicine Industry Dynamic
2.3.1 Antiviral Traditional Chinese Medicine Market Trends
2.3.2 Antiviral Traditional Chinese Medicine Market Drivers
2.3.3 Antiviral Traditional Chinese Medicine Market Challenges
2.3.4 Antiviral Traditional Chinese Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiviral Traditional Chinese Medicine Players by Revenue
3.1.1 Global Top Antiviral Traditional Chinese Medicine Players by Revenue (2016-2021)
3.1.2 Global Antiviral Traditional Chinese Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Antiviral Traditional Chinese Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antiviral Traditional Chinese Medicine Revenue
3.4 Global Antiviral Traditional Chinese Medicine Market Concentration Ratio
3.4.1 Global Antiviral Traditional Chinese Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiviral Traditional Chinese Medicine Revenue in 2020
3.5 Antiviral Traditional Chinese Medicine Key Players Head office and Area Served
3.6 Key Players Antiviral Traditional Chinese Medicine Product Solution and Service
3.7 Date of Enter into Antiviral Traditional Chinese Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiviral Traditional Chinese Medicine Breakdown Data by Type
4.1 Global Antiviral Traditional Chinese Medicine Historic Market Size by Type (2016-2021)
4.2 Global Antiviral Traditional Chinese Medicine Forecasted Market Size by Type (2022-2027)
5 Antiviral Traditional Chinese Medicine Breakdown Data by Application
5.1 Global Antiviral Traditional Chinese Medicine Historic Market Size by Application (2016-2021)
5.2 Global Antiviral Traditional Chinese Medicine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Antiviral Traditional Chinese Medicine Market Size (2016-2027)
6.2 North America Antiviral Traditional Chinese Medicine Market Size by Type
6.2.1 North America Antiviral Traditional Chinese Medicine Market Size by Type (2016-2021)
6.2.2 North America Antiviral Traditional Chinese Medicine Market Size by Type (2022-2027)
6.2.3 North America Antiviral Traditional Chinese Medicine Market Size by Type (2016-2027)
6.3 North America Antiviral Traditional Chinese Medicine Market Size by Application
6.3.1 North America Antiviral Traditional Chinese Medicine Market Size by Application (2016-2021)
6.3.2 North America Antiviral Traditional Chinese Medicine Market Size by Application (2022-2027)
6.3.3 North America Antiviral Traditional Chinese Medicine Market Size by Application (2016-2027)
6.4 North America Antiviral Traditional Chinese Medicine Market Size by Country
6.4.1 North America Antiviral Traditional Chinese Medicine Market Size by Country (2016-2021)
6.4.2 North America Antiviral Traditional Chinese Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Antiviral Traditional Chinese Medicine Market Size (2016-2027)
7.2 Europe Antiviral Traditional Chinese Medicine Market Size by Type
7.2.1 Europe Antiviral Traditional Chinese Medicine Market Size by Type (2016-2021)
7.2.2 Europe Antiviral Traditional Chinese Medicine Market Size by Type (2022-2027)
7.2.3 Europe Antiviral Traditional Chinese Medicine Market Size by Type (2016-2027)
7.3 Europe Antiviral Traditional Chinese Medicine Market Size by Application
7.3.1 Europe Antiviral Traditional Chinese Medicine Market Size by Application (2016-2021)
7.3.2 Europe Antiviral Traditional Chinese Medicine Market Size by Application (2022-2027)
7.3.3 Europe Antiviral Traditional Chinese Medicine Market Size by Application (2016-2027)
7.4 Europe Antiviral Traditional Chinese Medicine Market Size by Country
7.4.1 Europe Antiviral Traditional Chinese Medicine Market Size by Country (2016-2021)
7.4.2 Europe Antiviral Traditional Chinese Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Antiviral Traditional Chinese Medicine Market Size (2016-2027)
8.2 Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Type
8.2.1 Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Application
8.3.1 Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Region
8.4.1 Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Antiviral Traditional Chinese Medicine Market Size (2016-2027)
9.2 Latin America Antiviral Traditional Chinese Medicine Market Size by Type
9.2.1 Latin America Antiviral Traditional Chinese Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Antiviral Traditional Chinese Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Antiviral Traditional Chinese Medicine Market Size by Type (2016-2027)
9.3 Latin America Antiviral Traditional Chinese Medicine Market Size by Application
9.3.1 Latin America Antiviral Traditional Chinese Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Antiviral Traditional Chinese Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Antiviral Traditional Chinese Medicine Market Size by Application (2016-2027)
9.4 Latin America Antiviral Traditional Chinese Medicine Market Size by Country
9.4.1 Latin America Antiviral Traditional Chinese Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Antiviral Traditional Chinese Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiviral Traditional Chinese Medicine Market Size (2016-2027)
10.2 Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Type
10.2.1 Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Application
10.3.1 Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Country
10.4.1 Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Guangzhou Pharmaceutical
11.1.1 Guangzhou Pharmaceutical Company Details
11.1.2 Guangzhou Pharmaceutical Business Overview
11.1.3 Guangzhou Pharmaceutical Antiviral Traditional Chinese Medicine Introduction
11.1.4 Guangzhou Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.1.5 Guangzhou Pharmaceutical Recent Development
11.2 CR SANJIU
11.2.1 CR SANJIU Company Details
11.2.2 CR SANJIU Business Overview
11.2.3 CR SANJIU Antiviral Traditional Chinese Medicine Introduction
11.2.4 CR SANJIU Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.2.5 CR SANJIU Recent Development
11.3 TASLY
11.3.1 TASLY Company Details
11.3.2 TASLY Business Overview
11.3.3 TASLY Antiviral Traditional Chinese Medicine Introduction
11.3.4 TASLY Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.3.5 TASLY Recent Development
11.4 China TCM
11.4.1 China TCM Company Details
11.4.2 China TCM Business Overview
11.4.3 China TCM Antiviral Traditional Chinese Medicine Introduction
11.4.4 China TCM Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.4.5 China TCM Recent Development
11.5 Yunnan Baiyao
11.5.1 Yunnan Baiyao Company Details
11.5.2 Yunnan Baiyao Business Overview
11.5.3 Yunnan Baiyao Antiviral Traditional Chinese Medicine Introduction
11.5.4 Yunnan Baiyao Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.5.5 Yunnan Baiyao Recent Development
11.6 Tongrentang
11.6.1 Tongrentang Company Details
11.6.2 Tongrentang Business Overview
11.6.3 Tongrentang Antiviral Traditional Chinese Medicine Introduction
11.6.4 Tongrentang Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.6.5 Tongrentang Recent Development
11.7 Jumpcan
11.7.1 Jumpcan Company Details
11.7.2 Jumpcan Business Overview
11.7.3 Jumpcan Antiviral Traditional Chinese Medicine Introduction
11.7.4 Jumpcan Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.7.5 Jumpcan Recent Development
11.8 Zhejiang Conba Pharmaceutical
11.8.1 Zhejiang Conba Pharmaceutical Company Details
11.8.2 Zhejiang Conba Pharmaceutical Business Overview
11.8.3 Zhejiang Conba Pharmaceutical Antiviral Traditional Chinese Medicine Introduction
11.8.4 Zhejiang Conba Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.8.5 Zhejiang Conba Pharmaceutical Recent Development
11.9 Green Valley Pharma
11.9.1 Green Valley Pharma Company Details
11.9.2 Green Valley Pharma Business Overview
11.9.3 Green Valley Pharma Antiviral Traditional Chinese Medicine Introduction
11.9.4 Green Valley Pharma Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.9.5 Green Valley Pharma Recent Development
11.10 Changbaishan Pharmaceutical
11.10.1 Changbaishan Pharmaceutical Company Details
11.10.2 Changbaishan Pharmaceutical Business Overview
11.10.3 Changbaishan Pharmaceutical Antiviral Traditional Chinese Medicine Introduction
11.10.4 Changbaishan Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.10.5 Changbaishan Pharmaceutical Recent Development
11.11 Zhejiang Kanglaite Pharmaceutical
11.11.1 Zhejiang Kanglaite Pharmaceutical Company Details
11.11.2 Zhejiang Kanglaite Pharmaceutical Business Overview
11.11.3 Zhejiang Kanglaite Pharmaceutical Antiviral Traditional Chinese Medicine Introduction
11.11.4 Zhejiang Kanglaite Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.11.5 Zhejiang Kanglaite Pharmaceutical Recent Development
11.12 Qingfeng Pharmaceutical Group
11.12.1 Qingfeng Pharmaceutical Group Company Details
11.12.2 Qingfeng Pharmaceutical Group Business Overview
11.12.3 Qingfeng Pharmaceutical Group Antiviral Traditional Chinese Medicine Introduction
11.12.4 Qingfeng Pharmaceutical Group Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.12.5 Qingfeng Pharmaceutical Group Recent Development
11.13 Buchang Pharmaceutical
11.13.1 Buchang Pharmaceutical Company Details
11.13.2 Buchang Pharmaceutical Business Overview
11.13.3 Buchang Pharmaceutical Antiviral Traditional Chinese Medicine Introduction
11.13.4 Buchang Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.13.5 Buchang Pharmaceutical Recent Development
11.14 Livzon
11.14.1 Livzon Company Details
11.14.2 Livzon Business Overview
11.14.3 Livzon Antiviral Traditional Chinese Medicine Introduction
11.14.4 Livzon Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.14.5 Livzon Recent Development
11.15 ZBD Pharmaceutical
11.15.1 ZBD Pharmaceutical Company Details
11.15.2 ZBD Pharmaceutical Business Overview
11.15.3 ZBD Pharmaceutical Antiviral Traditional Chinese Medicine Introduction
11.15.4 ZBD Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.15.5 ZBD Pharmaceutical Recent Development
11.16 Chase Sun Pharmaceutical
11.16.1 Chase Sun Pharmaceutical Company Details
11.16.2 Chase Sun Pharmaceutical Business Overview
11.16.3 Chase Sun Pharmaceutical Antiviral Traditional Chinese Medicine Introduction
11.16.4 Chase Sun Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.16.5 Chase Sun Pharmaceutical Recent Development
11.17 Wuzhou Pharmaceutical
11.17.1 Wuzhou Pharmaceutical Company Details
11.17.2 Wuzhou Pharmaceutical Business Overview
11.17.3 Wuzhou Pharmaceutical Antiviral Traditional Chinese Medicine Introduction
11.17.4 Wuzhou Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.17.5 Wuzhou Pharmaceutical Recent Development
11.18 Yusheng Pharmaceutical
11.18.1 Yusheng Pharmaceutical Company Details
11.18.2 Yusheng Pharmaceutical Business Overview
11.18.3 Yusheng Pharmaceutical Antiviral Traditional Chinese Medicine Introduction
11.18.4 Yusheng Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.18.5 Yusheng Pharmaceutical Recent Development
11.18 Harbin Pharmaceutical Group
.1 Harbin Pharmaceutical Group Company Details
.2 Harbin Pharmaceutical Group Business Overview
.3 Harbin Pharmaceutical Group Antiviral Traditional Chinese Medicine Introduction
.4 Harbin Pharmaceutical Group Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
.5 Harbin Pharmaceutical Group Recent Development
11.20 Fusen Pharmaceutical
11.20.1 Fusen Pharmaceutical Company Details
11.20.2 Fusen Pharmaceutical Business Overview
11.20.3 Fusen Pharmaceutical Antiviral Traditional Chinese Medicine Introduction
11.20.4 Fusen Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.20.5 Fusen Pharmaceutical Recent Development
11.21 Gerun Pharmaceutical
11.21.1 Gerun Pharmaceutical Company Details
11.21.2 Gerun Pharmaceutical Business Overview
11.21.3 Gerun Pharmaceutical Antiviral Traditional Chinese Medicine Introduction
11.21.4 Gerun Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.21.5 Gerun Pharmaceutical Recent Development
11.22 Shineway Pharmaceutical
11.22.1 Shineway Pharmaceutical Company Details
11.22.2 Shineway Pharmaceutical Business Overview
11.22.3 Shineway Pharmaceutical Antiviral Traditional Chinese Medicine Introduction
11.22.4 Shineway Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.22.5 Shineway Pharmaceutical Recent Development
11.23 Yiling Pharmaceutical
11.23.1 Yiling Pharmaceutical Company Details
11.23.2 Yiling Pharmaceutical Business Overview
11.23.3 Yiling Pharmaceutical Antiviral Traditional Chinese Medicine Introduction
11.23.4 Yiling Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.23.5 Yiling Pharmaceutical Recent Development
11.24 Harbin Pharmaceutical Group
11.24.1 Harbin Pharmaceutical Group Company Details
11.24.2 Harbin Pharmaceutical Group Business Overview
11.24.3 Harbin Pharmaceutical Group Antiviral Traditional Chinese Medicine Introduction
11.24.4 Harbin Pharmaceutical Group Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021)
11.24.5 Harbin Pharmaceutical Group Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Antiviral Traditional Chinese Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-HIV
Table 3. Key Players of Anti-CVB
Table 4. Key Players of Anti-HBV
Table 5. Key Players of Anti-influenza Virus
Table 6. Key Players of Anti-herpes Virus
Table 7. Key Players of Other
Table 8. Global Antiviral Traditional Chinese Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Antiviral Traditional Chinese Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Antiviral Traditional Chinese Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Antiviral Traditional Chinese Medicine Market Share by Regions (2016-2021)
Table 12. Global Antiviral Traditional Chinese Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Antiviral Traditional Chinese Medicine Market Share by Regions (2022-2027)
Table 14. Antiviral Traditional Chinese Medicine Market Trends
Table 15. Antiviral Traditional Chinese Medicine Market Drivers
Table 16. Antiviral Traditional Chinese Medicine Market Challenges
Table 17. Antiviral Traditional Chinese Medicine Market Restraints
Table 18. Global Antiviral Traditional Chinese Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Antiviral Traditional Chinese Medicine Market Share by Players (2016-2021)
Table 20. Global Top Antiviral Traditional Chinese Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiviral Traditional Chinese Medicine as of 2020)
Table 21. Ranking of Global Top Antiviral Traditional Chinese Medicine Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Antiviral Traditional Chinese Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Antiviral Traditional Chinese Medicine Product Solution and Service
Table 25. Date of Enter into Antiviral Traditional Chinese Medicine Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Antiviral Traditional Chinese Medicine Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Antiviral Traditional Chinese Medicine Revenue Market Share by Type (2016-2021)
Table 29. Global Antiviral Traditional Chinese Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Antiviral Traditional Chinese Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Antiviral Traditional Chinese Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Antiviral Traditional Chinese Medicine Revenue Market Share by Application (2016-2021)
Table 33. Global Antiviral Traditional Chinese Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Antiviral Traditional Chinese Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Antiviral Traditional Chinese Medicine Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Antiviral Traditional Chinese Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Antiviral Traditional Chinese Medicine Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Antiviral Traditional Chinese Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Antiviral Traditional Chinese Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Antiviral Traditional Chinese Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Antiviral Traditional Chinese Medicine Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Antiviral Traditional Chinese Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Antiviral Traditional Chinese Medicine Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Antiviral Traditional Chinese Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Antiviral Traditional Chinese Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Antiviral Traditional Chinese Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Antiviral Traditional Chinese Medicine Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Antiviral Traditional Chinese Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Antiviral Traditional Chinese Medicine Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Antiviral Traditional Chinese Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Antiviral Traditional Chinese Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Antiviral Traditional Chinese Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 65. Guangzhou Pharmaceutical Company Details
Table 66. Guangzhou Pharmaceutical Business Overview
Table 67. Guangzhou Pharmaceutical Antiviral Traditional Chinese Medicine Product
Table 68. Guangzhou Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 69. Guangzhou Pharmaceutical Recent Development
Table 70. CR SANJIU Company Details
Table 71. CR SANJIU Business Overview
Table 72. CR SANJIU Antiviral Traditional Chinese Medicine Product
Table 73. CR SANJIU Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 74. CR SANJIU Recent Development
Table 75. TASLY Company Details
Table 76. TASLY Business Overview
Table 77. TASLY Antiviral Traditional Chinese Medicine Product
Table 78. TASLY Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 79. TASLY Recent Development
Table 80. China TCM Company Details
Table 81. China TCM Business Overview
Table 82. China TCM Antiviral Traditional Chinese Medicine Product
Table 83. China TCM Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 84. China TCM Recent Development
Table 85. Yunnan Baiyao Company Details
Table 86. Yunnan Baiyao Business Overview
Table 87. Yunnan Baiyao Antiviral Traditional Chinese Medicine Product
Table 88. Yunnan Baiyao Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 89. Yunnan Baiyao Recent Development
Table 90. Tongrentang Company Details
Table 91. Tongrentang Business Overview
Table 92. Tongrentang Antiviral Traditional Chinese Medicine Product
Table 93. Tongrentang Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 94. Tongrentang Recent Development
Table 95. Jumpcan Company Details
Table 96. Jumpcan Business Overview
Table 97. Jumpcan Antiviral Traditional Chinese Medicine Product
Table 98. Jumpcan Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 99. Jumpcan Recent Development
Table 100. Zhejiang Conba Pharmaceutical Company Details
Table 101. Zhejiang Conba Pharmaceutical Business Overview
Table 102. Zhejiang Conba Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 103. Zhejiang Conba Pharmaceutical Recent Development
Table 104. Green Valley Pharma Company Details
Table 105. Green Valley Pharma Business Overview
Table 106. Green Valley Pharma Antiviral Traditional Chinese Medicine Product
Table 107. Green Valley Pharma Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 108. Green Valley Pharma Recent Development
Table 109. Changbaishan Pharmaceutical Company Details
Table 110. Changbaishan Pharmaceutical Business Overview
Table 111. Changbaishan Pharmaceutical Antiviral Traditional Chinese Medicine Product
Table 112. Changbaishan Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 113. Changbaishan Pharmaceutical Recent Development
Table 114. Zhejiang Kanglaite Pharmaceutical Company Details
Table 115. Zhejiang Kanglaite Pharmaceutical Business Overview
Table 116. Zhejiang Kanglaite Pharmaceutical Antiviral Traditional Chinese Medicine Product
Table 117. Zhejiang Kanglaite Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 118. Zhejiang Kanglaite Pharmaceutical Recent Development
Table 119. Qingfeng Pharmaceutical Group Company Details
Table 120. Qingfeng Pharmaceutical Group Business Overview
Table 121. Qingfeng Pharmaceutical Group Antiviral Traditional Chinese Medicine Product
Table 122. Qingfeng Pharmaceutical Group Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 123. Qingfeng Pharmaceutical Group Recent Development
Table 124. Buchang Pharmaceutical Company Details
Table 125. Buchang Pharmaceutical Business Overview
Table 126. Buchang Pharmaceutical Antiviral Traditional Chinese Medicine Product
Table 127. Buchang Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 128. Buchang Pharmaceutical Recent Development
Table 129. Livzon Company Details
Table 130. Livzon Business Overview
Table 131. Livzon Antiviral Traditional Chinese Medicine Product
Table 132. Livzon Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 133. Livzon Recent Development
Table 134. ZBD Pharmaceutical Company Details
Table 135. ZBD Pharmaceutical Business Overview
Table 136. ZBD Pharmaceutical Antiviral Traditional Chinese Medicine Product
Table 137. ZBD Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 138. ZBD Pharmaceutical Recent Development
Table 139. Chase Sun Pharmaceutical Company Details
Table 140. Chase Sun Pharmaceutical Business Overview
Table 141. Chase Sun Pharmaceutical Antiviral Traditional Chinese Medicine Product
Table 142. Chase Sun Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 143. Chase Sun Pharmaceutical Recent Development
Table 144. Wuzhou Pharmaceutical Company Details
Table 145. Wuzhou Pharmaceutical Business Overview
Table 146. Wuzhou Pharmaceutical Antiviral Traditional Chinese Medicine Product
Table 147. Wuzhou Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 148. Wuzhou Pharmaceutical Recent Development
Table 149. Yusheng Pharmaceutical Company Details
Table 150. Yusheng Pharmaceutical Business Overview
Table 151. Yusheng Pharmaceutical Antiviral Traditional Chinese Medicine Product
Table 152. Yusheng Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 153. Yusheng Pharmaceutical Recent Development
Table 154. Harbin Pharmaceutical Group Company Details
Table 155. Harbin Pharmaceutical Group Business Overview
Table 156. Harbin Pharmaceutical Group Antiviral Traditional Chinese Medicine Product
Table 157. Harbin Pharmaceutical Group Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 158. Harbin Pharmaceutical Group Recent Development
Table 159. Fusen Pharmaceutical Company Details
Table 160. Fusen Pharmaceutical Business Overview
Table 161. Fusen Pharmaceutical Antiviral Traditional Chinese Medicine Product
Table 162. Fusen Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 163. Fusen Pharmaceutical Recent Development
Table 164. Gerun Pharmaceutical Company Details
Table 165. Gerun Pharmaceutical Business Overview
Table 166. Gerun Pharmaceutical Antiviral Traditional Chinese Medicine Product
Table 167. Gerun Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 168. Gerun Pharmaceutical Recent Development
Table 169. Shineway Pharmaceutical Company Details
Table 170. Shineway Pharmaceutical Business Overview
Table 171. Shineway Pharmaceutical Antiviral Traditional Chinese Medicine Product
Table 172. Shineway Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 173. Shineway Pharmaceutical Recent Development
Table 174. Yiling Pharmaceutical Company Details
Table 175. Yiling Pharmaceutical Business Overview
Table 176. Yiling Pharmaceutical Antiviral Traditional Chinese Medicine Product
Table 177. Yiling Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 178. Yiling Pharmaceutical Recent Development
Table 179. Harbin Pharmaceutical Group Company Details
Table 180. Harbin Pharmaceutical Group Business Overview
Table 181. Harbin Pharmaceutical Group Antiviral Traditional Chinese MedicineProduct
Table 182. Harbin Pharmaceutical Group Revenue in Antiviral Traditional Chinese Medicine Business (2016-2021) & (US$ Million)
Table 183. Harbin Pharmaceutical Group Recent Development
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiviral Traditional Chinese Medicine Market Share by Type: 2020 VS 2027
Figure 2. Anti-HIV Features
Figure 3. Anti-CVB Features
Figure 4. Anti-HBV Features
Figure 5. Anti-influenza Virus Features
Figure 6. Anti-herpes Virus Features
Figure 7. Other Features
Figure 8. Global Antiviral Traditional Chinese Medicine Market Share by Application: 2020 VS 2027
Figure 9. Adult Case Studies
Figure 10. Children Case Studies
Figure 11. Antiviral Traditional Chinese Medicine Report Years Considered
Figure 12. Global Antiviral Traditional Chinese Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Antiviral Traditional Chinese Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Antiviral Traditional Chinese Medicine Market Share by Regions: 2020 VS 2027
Figure 15. Global Antiviral Traditional Chinese Medicine Market Share by Regions (2022-2027)
Figure 16. Global Antiviral Traditional Chinese Medicine Market Share by Players in 2020
Figure 17. Global Top Antiviral Traditional Chinese Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiviral Traditional Chinese Medicine as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Antiviral Traditional Chinese Medicine Revenue in 2020
Figure 19. Global Antiviral Traditional Chinese Medicine Revenue Market Share by Type (2016-2021)
Figure 20. Global Antiviral Traditional Chinese Medicine Revenue Market Share by Type (2022-2027)
Figure 21. North America Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Antiviral Traditional Chinese Medicine Market Share by Type (2016-2027)
Figure 23. North America Antiviral Traditional Chinese Medicine Market Share by Application (2016-2027)
Figure 24. North America Antiviral Traditional Chinese Medicine Market Share by Country (2016-2027)
Figure 25. United States Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Antiviral Traditional Chinese Medicine Market Share by Type (2016-2027)
Figure 29. Europe Antiviral Traditional Chinese Medicine Market Share by Application (2016-2027)
Figure 30. Europe Antiviral Traditional Chinese Medicine Market Share by Country (2016-2027)
Figure 31. Germany Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Antiviral Traditional Chinese Medicine Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Antiviral Traditional Chinese Medicine Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Antiviral Traditional Chinese Medicine Market Share by Region (2016-2027)
Figure 41. China Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Antiviral Traditional Chinese Medicine Market Share by Type (2016-2027)
Figure 49. Latin America Antiviral Traditional Chinese Medicine Market Share by Application (2016-2027)
Figure 50. Latin America Antiviral Traditional Chinese Medicine Market Share by Country (2016-2027)
Figure 51. Mexico Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Antiviral Traditional Chinese Medicine Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Antiviral Traditional Chinese Medicine Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Antiviral Traditional Chinese Medicine Market Share by Country (2016-2027)
Figure 57. Turkey Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Antiviral Traditional Chinese Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Guangzhou Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 61. CR SANJIU Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 62. TASLY Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 63. China TCM Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 64. Yunnan Baiyao Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 65. Tongrentang Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 66. Jumpcan Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 67. Zhejiang Conba Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 68. Green Valley Pharma Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 69. Changbaishan Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 70. Zhejiang Kanglaite Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 71. Qingfeng Pharmaceutical Group Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 72. Buchang Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 73. Livzon Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 74. ZBD Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 75. Chase Sun Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 76. Wuzhou Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 77. Yusheng Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 78. Harbin Pharmaceutical Group Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 79. Fusen Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 80. Gerun Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 81. Shineway Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 82. Yiling Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 83. Harbin Pharmaceutical Group Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2016-2021)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
世界の新型コロナウイルス感染症用従来型漢方薬市場規模・現状・予測（2021年-2027年） At present, the global COVID-19 epidemic is progressing rapidly. Chinese medicine has a long history and plays an indispensable role in the prevention and treatment of various epidemics. During the treatment of COVID-19, the intervention of Chinese medicine has also achieved remarkable results. In 2…- 世界の伝統型漢方薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Traditional Chinese Herbal Medicine Market The global Traditional Chinese Herbal Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…
- 世界の漢方解熱剤市場規模・現状・予測（2021年-2027年） It is generally composed mainly of heat-clearing drugs, which have functions of clearing heat, purging fire, cooling blood and detoxifying, etc., and are used for internal heat, fire poison, damp heat, pestilence and other kinds of proprietary Chinese medicine in heat syndrome, collectively referred…
- 世界の抗糖尿病薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-diabetic Medication Market The global Anti-diabetic Medication market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界のアンチエイジング成分市場規模・現状・予測（2021年-2027年） Anti-aging supplements are a set of products that often include powdered supplements, skin creams, vitamins, and facial masks. Collagen peptides can reduce signs of aging by stimulating new collagen growth, promoting collagen production, and relaxing wrinkles. They are also a natural source of prote…